This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Andreas Grüntzig was a German cardiologist best known for being the first to develop successful balloon angioplasty for expanding lumens of narrowed arteries. It’s a celebration of the amazing innovation that has occurred in structural heartdisease therapy over the last 20 years and I’m proud to be part of it.
Fellows 2024 offers hands-on training covering revascularization, angioplasty, stents, pharmacologic therapy, and intravascular imaging/physiology. Noncoronary topics like structural heartdisease and vascular medicine are also addressed. The course is relevant for the entire heart valve team.
24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.
Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. Incentives Prompt Increased Daily Walking in Patients at Risk for HeartDisease 6. Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable 9.
HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. It’s an honor to have the U.S.’s
The aim of this day is to encourage individuals and healthcare professionals, particularly cardiologists, to take proactive measures in preventing heartdiseases. The Role of Cardiologists Cardiologists are at the forefront of the battle against heartdiseases.
As a result, an ECG monitor is attached to the patient immediately upon arrival at the hospital to assess their heart rhythm and provide appropriate treatment in the event of an abnormal rhythm. Although both techniques have advantages and limitations, primary angioplasty is the chosen therapy in most cases. Maintain a healthy weight.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content